Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Endocrine Testing Market to Reach US$ 13 Billion By 2023

Market Research Engine
Posted on: 02 Oct 16
Endocrine Testing Market to Reach US$ 13 Billion By 2023

New York, October 03: Market Research Engine has published a new report titled as “Endocrine Testing Market - Global Industry Analysis, Size, Share, Growth Trends and Forecast, 2015 - 2023”

The global endocrine testing market was valued at US$6 billion in 2014 and is estimated to reach near about US$ 13 billion by 2023 at a CAGR of 8.8% from 2015 to 2023.

Download Free Sample Report:

Endocrinology is a science of the study of Endocrine glands its structure and functions. The Endocrine glands consists of pituitary glands, thyroid glands, adrenal glands and pancreas. The Endocrine glands secrete hormones directly into the main blood stream and help in the normal body functions. The endocrine tests help in detecting the deviations in the secretion of the hormones which is helpful to understand the disorders like infertility, menopause, thyroid dysfunction.

The major driving factors of Endocrine Testing market are as follows:

•    The occurrences of endocrine disorders are increasing these days such as diabetes, thyroid disorders, and infertility.
•    The advancement of the technology
•    Increasing health care awareness.

The restraints factors of Endocrine testing market are as follows:

•    The high cost of development of the technology.

The Endocrine Testing market is segmented on the lines of its Test, Diagnostic technology, End User.  The Endocrine Testing market is segmented on the lines of its Test type like Follicle stimulating hormone(FSH) Human Chorionic Gonadotropin (hCG) Thyroid stimulating Hormone(TSH) Dehydroepiandrosterone sulfate (DHEAS) Prolactin Progesterone Insulin Cortisol Testosterone Estradiol(E2) Luteinizing Hormone (LH). The Endocrine Testing market is segmented on the lines of its Diagnostic Technology as Immunoassay Clinical Chemistry Monoclonal and Polyclonal Antibody Tandem Mass Spectroscopy. The Endocrine Testing market is segmented on the lines of its End User as Hospitals Physicians Offices Health Care Centers Commercial Laboratories

Browse Full Report:

The Endocrine Testing market geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

This report provides:

1) An overview of the global market for Endocrine Testing and related technologies.
2) Analyses of global market trends and projections of compound annual growth rates (CAGRs) through 2020.
3) Identifications of new market opportunities and targeted promotional plans for Endocrine Testing market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.


The scope of the report includes a detailed study of global and regional markets for various types of Endocrine Testing market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Quest Diagnostics, Thermo Fisher Scientific, Siemens Healthcare, Ortho Clinical Diagnostics, bioMerieux, Agilent Technologies, Abbott Laboratories and others. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

The endocrine testing market is segmented as follows:  

Market by Test

•    Follicle stimulating hormone(FSH)
•    Human Chorionic Gonadotropin (hCG)
•    Thyroid Stimulating Hormone(TSH)
•    Dehydroepiandrosterone sulfate (DHEAS)
•    Prolactin
•    Progesterone
•    Insulin
•    Cortisol
•    Testosterone
•    Estradiol(E2)
•    Luteinizing Hormone (LH)

Market by Diagnostic Technology

•    Immunoassay
•    Clinical Chemistry
•    Monoclonal and Polyclonal Antibody
•    Tandem Mass Spectroscopy

Market by End User

•    Hospitals
•    Physicians Offices
•    Health Care Centers
•    Commercial Laboratories

Market by Geography

•    North America
•    Europe
•    Asia Pacific
•    RoW

For more information:

Editor's Details

John Bay
Market Research Engine

Last updated on: 02/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.